human circrna arrays arraystar rockville, md (Arraystar inc)
Structured Review

Human Circrna Arrays Arraystar Rockville, Md, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+arraystar+circrna+array/pmc06617429-56-19-22?v=Arraystar+inc
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Circular RNA expression profile in peripheral blood mononuclear cells from Crohn disease patients"
Article Title: Circular RNA expression profile in peripheral blood mononuclear cells from Crohn disease patients
Journal: Medicine
doi: 10.1097/MD.0000000000016072
Figure Legend Snippet: CircRNA expression profiles of CD patients (n = 5) in comparison with HCs (n = 5) screened by microarray analysis. A, Boxplot view showed the distribution of normalized intensity values for CD patients (T12, T40, T49, and T51) and HCs (C1, C2, C3, C4, and C5). B, Scatter plot indicated the variation of circRNA expression between groups. Dots outside the green lines represented circRNAs with logarithmized expression changes greater than 2-fold between groups. C, Volcano plots showed the values of FC and P of the microarray data. Red dots indicated significantly dysregulated circRNAs. D, Hierarchical clustering revealed circRNA expression profiles of CD and HCs. Red color strip represented relatively high expression, while green color one indicated relatively low expression. circRNA = circular RNA, CD = Crohn disease, FC = fold-change, HCs = health controls.
Techniques Used: Expressing, Comparison, Microarray, Stripping Membranes
Figure Legend Snippet: Verification of the relatively expression level of 5 up-regulated circRNAs (092520, 102610, 004662, 103124, and 103546) by RT-PCR and qPCR. PBMCs from 52 CD patients and 38 HCs were used for initial verification. CircRNA_004662 was further validated in 87 CD patients and 55 HCs and 50 UC patients. The statistical significance between CD, UC, and HCs was calculated by Student t test or one-way ANOVA. A, The relative expression of circRNA_09250. B, The relative expression of circRNA_102610. C, The relative expression of circRNA_004662. D, The relative expression of circRNA_103124. E, The relative expression of circRNA_103546. P < .05 was considered as statistically significant. ∗ P = .01; ∗∗ P < .001. ANOVA = analysis of variance, CD = Crohn disease,circRNA = circular RNA, HCs = health controls, qPCR = quantitative polymerase chain reaction, RT-PCR = reverse transcription polymerase chain reaction, PBMCs = peripheral blood mononuclear cells, UC = ulcerative colitis.
Techniques Used: Expressing, Reverse Transcription Polymerase Chain Reaction, Real-time Polymerase Chain Reaction, Reverse Transcription, Polymerase Chain Reaction
Figure Legend Snippet: ROC curve analysis to evaluate diagnostic value of validated circRNAs. Four up-regulated circRNAs (103124, 004662, 102610, and 092520) verified were analyzed. AUC = area under curve, circRNA = circular RNA, CI = confidence interval, ROC = receiver operating characteristic, SEM = standard error of mean.
Techniques Used: Diagnostic Assay
Figure Legend Snippet: CircRNA_004662 and the 5 most potential target miRNAs predicted. miRNAs that may bind to circRNA were predicted by TargetScan and miRanda. circRNA = circular RNA, miRNA = microRNA.
Techniques Used:
Figure Legend Snippet: Network of circRNA_004662-miRNA-mRNA. circRNA = circular RNA, miRNA = microRNA.
Techniques Used:
